Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Keynote and Plenary Sessions
Concurrent Sessions
Event

Playback speed

10 seconds

The Use of CRISPR Technology in the Treatment of Malignant and Non-malignant Diseases: Making CAR T-Cells "CRISPeR"

By Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium FEATURING Edward Stadtmauer

0 views

September 9, 2021

Comments 0

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Concurrent Sessions

14:13

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Neurotoxicity After CAR T-Cell Therapy: Pathophysiology and Therapeu…

Feat. S. Kenderian

14:30

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

CAR T-Cells - Beyond the Storm: Long-Term Toxicities, Hypogammaglobu…

Feat. N. Shah

12:39

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Future of Gene Therapy in Pediatrics Q&A Session

Feat. T. Olson, M. Porteus

16:25

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Implication of Gene Therapy Treatment in Pediatrics Q&…

Feat. T. Olson, S. Pai, A. Waldman, J. Kwiatkowski

18:20

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Q&A Nursing Panel on IO in Pediatrics: AML/CART 33 and U CART; C…

Feat. L. Smith, D. Baniewicz, C. Callahan

13:10

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Phase I Study of Autologous T-Cells Bearing Fully-Humanized CARs Tar…

Feat. J. Tanyi

12:39

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Updates on CAR T Prostate Cancer Trials

Feat. N. Haas

13:07

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Updates on T-Cell Antigen Couplers

Feat. J. Bramson

11:32

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

CARs in Fibrosis

Feat. J. Epstein

18:36

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Immunotherapy for Clonal Driver Neoantigens

Feat. G. Linette

10:53

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

TnMUC1-Targeted CAR T-Cells

Feat. M. O'Hara

10:21

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Driving CARs in Solid Tumors: The Promise and Challenges

Feat. P. Kebriaei

18:42

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

GBM Clinical Trials: Early Observations and Future Directions

Feat. D. O'Rourke

61:26

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Q&A Panels: Current State and Future Updates in CA…

Feat. P. Yingxiao Wang, J. Bramson, J. Fraietta, C. Buchholz, J. Epstein, M. Milone, J. Riley, B. Valamehr, S. Kulkarni, M. Smith, D. Chang, C. Annesley, S. Forman, K. Reinhard

15:44

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

CD19 CAR T “Booster” T-APCs

Feat. C. Annesley

10:01

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

CAR T Vaccine Booster: CMV Vaccine

Feat. S. Forman

15:15

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

CAARs for Antibody-Mediated Autoimmune Disease

Feat. M. Milone

13:01

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

CARs for HIV

Feat. J. Riley

12:06

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Engineering Remote-Controllable CAR T-Cells for Cancer Immunotherapy

Feat. P. Yingxiao Wang

30:02

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Antibody Discovery for New CAR Constructs

Feat. D. Siegel

25:52

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Gene Therapy for Inborn Errors of Immunity

Feat. S. Pai

13:17

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Implication of Gene Therapy in Pediatrics: Leukodystrophies

Feat. A. Waldman

19:36

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Hematopoietic Stem Cell-Based Gene Therapy: Clinical Impact and Curr…

Feat. T. Olson

12:50

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Engineering Genome Edited Cellular Therapies: A Biologic Biologic

Feat. M. Porteus

23:45

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Preparing for an Autologous Stem Cell Transplant

Feat. K. Salam, K. Mcdevitt

32:18

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Preparing Patients for an Allogeneic Transplant

Feat. R. Golding, L. Quinn

46:39

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

COVID-19 Management of Liquid Oncology Patients

Feat. A. Walsh, A. Rubin

36:24

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

An Update on Novel Immunotherapy Approaches in Multiple Myeloma

Feat. P. Mangan

27:33

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Allogeneic Stem Cell Transplantion: What to Expect After the 1st Year

Feat. L. Perry

26:16

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Immunotherapy in Pediatric AML: CART33 Nursing Considerations During…

Feat. D. Baniewicz

26:37

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Nursing Considerations for Universal CAR T-Cell Therapy in Pediatrics

Feat. C. Callahan

10:33

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Q&A Discussion: CRISPR Technology and CAR T-Cells

Feat. E. Stadtmauer, P. Mangan

11:58

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Nursing Q&A Panel: Implications for Patients With …

Feat. E. Tracy, C. White, E. Worster

25:05

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Adult Nursing Q&A Session: Autologous/Allogenic Transplant, COVI…

Feat. P. Mangan, L. Perry, A. Walsh, A. Rubin, R. Golding, L. Quinn, K. Salam, K. Mcdevitt

29:04

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Nursing Considerations: Implications for Patients with SCD in the Er…

Feat. E. Worster, C. White

44:08

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

The Use of CRISPR Technology in the Treatment of Malignant and Non-m…

Feat. E. Stadtmauer